Because of Brexit Stern buys Smith & Nephew
Channel: Investing made easy
Date: 02/04/2016

Get our top 10 stock picks for free: https://o.obermatt.com/subscription/?utm_source=YouTube 
Be the first to get the Obermatt stock pick videos by email before they are listed on YouTube. You get the Obermatt Stock Investing Starter Kit - a short manual to get started with your own stock investing - for free if you subscribe to the free stock alert.

No April Fool’s joke: Obermatt calculated the UK top 10 stocks today (http://www.obermatt.com/en/index/ftse-100-ftse100/top-10-stocks-2016-03-25-78f41ce5.html); even though Brexit could crash the London exchanges.
Who knows the future?  No one can predict, especially Obermatt CEO Dr. Hermann J. Stern. But, thanks to our rule-based stock investment strategy, we don’t have to predict the future. We invest at regular intervals - independent of the stock markets fluctuations and emotions.
The known emotions are reflected in the stock prices anyway. Only changes to expectations have an effect on the prices. We better leave predicting future emotional changes to the psychotherapists, who know how to handle that much better than the typical investor.
For that reason, Stern will buy UK stocks today, despite the fact that the outlook for the UK seems bleak.  However, he can’t completely ignore his concerns about Brexit.  Banks will suffer the most from being excluded from the large European common market and their stocks are not a good buy.
Instead, Stern decides to purchase the global medical technology conglomerate, Smith & Nephew, because their products are still in demand even if there is a market crash.
With both value and safety ratings of 100, this stocks is just right for Stern, an investor that wants value and safety. Currently, growth is slow at Smith & Nephew as you can see from the Obermatt analysis: (http://www.obermatt.com/en/stocks/smith-nephew-sn-ln/stock-research.html). But, we can expect that the bright and talented management will reverse that trend eventually.

This post expresses the views of the author as of the date indicated. The author any other party connected to Obermatt have no duty or obligation to update the information contained herein.
Information is provided "as is" and solely for informational purposes and nothing else. Any investment decisions users take should be based on their own personal interpretation of the information available. The responsibility for investment decisions and their consequences lies solely with the user.
Investments in stocks are subject to risks. The historic performance presented in this post is no indication of future performance.  Moreover, wherever there is the potential for profit there is also the possibility of loss. Neither the author nor anyone at Obermatt or of its information providers are liable for any damages relating to the use of the information provided herein.